β-Human chorionic gonadotropin in cervicovaginal secretions as a predictor of preterm delivery

Peter S. Bernstein, R. Stern, N. Lin, J. Furgiuele, A. Karmen, M. Comerford-Freda, C. Chazotte

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

OBJECTIVE: This study's objective was to determine whether the concentrations of β-human chorionic gonadotropin in the secretions of the cervix and vagina could be used to predict preterm delivery in a group of women at high risk for this complication. STUDY DESIGN: Women attending a prematurity prevention clinic at an inner-city hospital July 1, 1996 October 1, 1997, were invited to participate. From those who consented, secretions from the cervix and posterior vaginal fornix were sampled every 2 weeks until delivery, beginning at 24 weeks' gestation. Concentrations of [β-human chorionic gonadotropin were measured with a commercially available enzyme- linked immunosorbent assay. Providers of obstetric care were blinded to the results. Levels of β-human chorionic gonadotropin in those who were delivered before 34 weeks' gestation and those who were delivered at term were compared. A value >50 mlU/mL was considered elevated. This cutoff value was determined according to β-human chorionic gonadotropin values obtained during pregnancies that were delivered at term. RESULTS: Of the 146 women asked to participate, 77 consented. There was no difference between participants and nonparticipants with respect to age, race, indication for enrollment in the clinic, gestational age at delivery, or parity. Of the 77 participants, 24 (31%) were delivered before 37 weeks' gestation and 12 (16%) were delivered before 34 weeks' gestation. A single β-human chorionic gonadotropin value >50 mlU/mL obtained between 24 and 28 weeks' gestation was associated with a significant increase in the incidence of delivery before 34 weeks' gestation (P = .03). This cutoff value had sensitivity, specificity, and positive and negative predictive values for predicting delivery before 34 weeks' gestation of 50%, 87%, 33%, and 93%, respectively. CONCLUSION: These data suggest that the concentration of C-human chorionic gonadotropin in cervicovaginal secretions may be a useful predictor of preterm delivery.

Original languageEnglish (US)
Pages (from-to)870-873
Number of pages4
JournalAmerican Journal of Obstetrics and Gynecology
Volume179
Issue number4
DOIs
StatePublished - 1998

Fingerprint

Chorionic Gonadotropin
Pregnancy
Cervix Uteri
Urban Hospitals
Vagina
Parity
Gestational Age
Obstetrics
Enzyme-Linked Immunosorbent Assay
Sensitivity and Specificity
Incidence

Keywords

  • β-Human chorionic gonadotropin
  • Preterm delivery
  • Preterm labor

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

β-Human chorionic gonadotropin in cervicovaginal secretions as a predictor of preterm delivery. / Bernstein, Peter S.; Stern, R.; Lin, N.; Furgiuele, J.; Karmen, A.; Comerford-Freda, M.; Chazotte, C.

In: American Journal of Obstetrics and Gynecology, Vol. 179, No. 4, 1998, p. 870-873.

Research output: Contribution to journalArticle

Bernstein, Peter S. ; Stern, R. ; Lin, N. ; Furgiuele, J. ; Karmen, A. ; Comerford-Freda, M. ; Chazotte, C. / β-Human chorionic gonadotropin in cervicovaginal secretions as a predictor of preterm delivery. In: American Journal of Obstetrics and Gynecology. 1998 ; Vol. 179, No. 4. pp. 870-873.
@article{fc4c74b253594bfd8bfd103bef90664f,
title = "β-Human chorionic gonadotropin in cervicovaginal secretions as a predictor of preterm delivery",
abstract = "OBJECTIVE: This study's objective was to determine whether the concentrations of β-human chorionic gonadotropin in the secretions of the cervix and vagina could be used to predict preterm delivery in a group of women at high risk for this complication. STUDY DESIGN: Women attending a prematurity prevention clinic at an inner-city hospital July 1, 1996 October 1, 1997, were invited to participate. From those who consented, secretions from the cervix and posterior vaginal fornix were sampled every 2 weeks until delivery, beginning at 24 weeks' gestation. Concentrations of [β-human chorionic gonadotropin were measured with a commercially available enzyme- linked immunosorbent assay. Providers of obstetric care were blinded to the results. Levels of β-human chorionic gonadotropin in those who were delivered before 34 weeks' gestation and those who were delivered at term were compared. A value >50 mlU/mL was considered elevated. This cutoff value was determined according to β-human chorionic gonadotropin values obtained during pregnancies that were delivered at term. RESULTS: Of the 146 women asked to participate, 77 consented. There was no difference between participants and nonparticipants with respect to age, race, indication for enrollment in the clinic, gestational age at delivery, or parity. Of the 77 participants, 24 (31{\%}) were delivered before 37 weeks' gestation and 12 (16{\%}) were delivered before 34 weeks' gestation. A single β-human chorionic gonadotropin value >50 mlU/mL obtained between 24 and 28 weeks' gestation was associated with a significant increase in the incidence of delivery before 34 weeks' gestation (P = .03). This cutoff value had sensitivity, specificity, and positive and negative predictive values for predicting delivery before 34 weeks' gestation of 50{\%}, 87{\%}, 33{\%}, and 93{\%}, respectively. CONCLUSION: These data suggest that the concentration of C-human chorionic gonadotropin in cervicovaginal secretions may be a useful predictor of preterm delivery.",
keywords = "β-Human chorionic gonadotropin, Preterm delivery, Preterm labor",
author = "Bernstein, {Peter S.} and R. Stern and N. Lin and J. Furgiuele and A. Karmen and M. Comerford-Freda and C. Chazotte",
year = "1998",
doi = "10.1016/S0002-9378(98)70180-2",
language = "English (US)",
volume = "179",
pages = "870--873",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - β-Human chorionic gonadotropin in cervicovaginal secretions as a predictor of preterm delivery

AU - Bernstein, Peter S.

AU - Stern, R.

AU - Lin, N.

AU - Furgiuele, J.

AU - Karmen, A.

AU - Comerford-Freda, M.

AU - Chazotte, C.

PY - 1998

Y1 - 1998

N2 - OBJECTIVE: This study's objective was to determine whether the concentrations of β-human chorionic gonadotropin in the secretions of the cervix and vagina could be used to predict preterm delivery in a group of women at high risk for this complication. STUDY DESIGN: Women attending a prematurity prevention clinic at an inner-city hospital July 1, 1996 October 1, 1997, were invited to participate. From those who consented, secretions from the cervix and posterior vaginal fornix were sampled every 2 weeks until delivery, beginning at 24 weeks' gestation. Concentrations of [β-human chorionic gonadotropin were measured with a commercially available enzyme- linked immunosorbent assay. Providers of obstetric care were blinded to the results. Levels of β-human chorionic gonadotropin in those who were delivered before 34 weeks' gestation and those who were delivered at term were compared. A value >50 mlU/mL was considered elevated. This cutoff value was determined according to β-human chorionic gonadotropin values obtained during pregnancies that were delivered at term. RESULTS: Of the 146 women asked to participate, 77 consented. There was no difference between participants and nonparticipants with respect to age, race, indication for enrollment in the clinic, gestational age at delivery, or parity. Of the 77 participants, 24 (31%) were delivered before 37 weeks' gestation and 12 (16%) were delivered before 34 weeks' gestation. A single β-human chorionic gonadotropin value >50 mlU/mL obtained between 24 and 28 weeks' gestation was associated with a significant increase in the incidence of delivery before 34 weeks' gestation (P = .03). This cutoff value had sensitivity, specificity, and positive and negative predictive values for predicting delivery before 34 weeks' gestation of 50%, 87%, 33%, and 93%, respectively. CONCLUSION: These data suggest that the concentration of C-human chorionic gonadotropin in cervicovaginal secretions may be a useful predictor of preterm delivery.

AB - OBJECTIVE: This study's objective was to determine whether the concentrations of β-human chorionic gonadotropin in the secretions of the cervix and vagina could be used to predict preterm delivery in a group of women at high risk for this complication. STUDY DESIGN: Women attending a prematurity prevention clinic at an inner-city hospital July 1, 1996 October 1, 1997, were invited to participate. From those who consented, secretions from the cervix and posterior vaginal fornix were sampled every 2 weeks until delivery, beginning at 24 weeks' gestation. Concentrations of [β-human chorionic gonadotropin were measured with a commercially available enzyme- linked immunosorbent assay. Providers of obstetric care were blinded to the results. Levels of β-human chorionic gonadotropin in those who were delivered before 34 weeks' gestation and those who were delivered at term were compared. A value >50 mlU/mL was considered elevated. This cutoff value was determined according to β-human chorionic gonadotropin values obtained during pregnancies that were delivered at term. RESULTS: Of the 146 women asked to participate, 77 consented. There was no difference between participants and nonparticipants with respect to age, race, indication for enrollment in the clinic, gestational age at delivery, or parity. Of the 77 participants, 24 (31%) were delivered before 37 weeks' gestation and 12 (16%) were delivered before 34 weeks' gestation. A single β-human chorionic gonadotropin value >50 mlU/mL obtained between 24 and 28 weeks' gestation was associated with a significant increase in the incidence of delivery before 34 weeks' gestation (P = .03). This cutoff value had sensitivity, specificity, and positive and negative predictive values for predicting delivery before 34 weeks' gestation of 50%, 87%, 33%, and 93%, respectively. CONCLUSION: These data suggest that the concentration of C-human chorionic gonadotropin in cervicovaginal secretions may be a useful predictor of preterm delivery.

KW - β-Human chorionic gonadotropin

KW - Preterm delivery

KW - Preterm labor

UR - http://www.scopus.com/inward/record.url?scp=0031738903&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031738903&partnerID=8YFLogxK

U2 - 10.1016/S0002-9378(98)70180-2

DO - 10.1016/S0002-9378(98)70180-2

M3 - Article

C2 - 9790361

AN - SCOPUS:0031738903

VL - 179

SP - 870

EP - 873

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 4

ER -